Cosponsor
Sign in

HR 1060 · in committee · significant

Modern Authentication of Pharmaceuticals Act of 2025

What this bill does

  • Oral solid controlled substance pills must contain machine-readable physical chemical identifiers to authenticate and track them.
  • Pharmaceutical manufacturers and consumers of prescription controlled medications are affected by this requirement.
  • Manufacturers have five years after enactment to comply with the new authentication standards.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    How would embedding machine-readable identifiers into controlled substance pills help prevent counterfeit medications from reaching patients?

  2. 02

    What costs might pharmaceutical manufacturers face implementing this authentication technology, and who would bear those expenses?

  3. 03

    Could this tracking requirement create privacy concerns for patients taking prescription controlled substances, and how might those be addressed?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · D-NC-1

Donald G. Davis

Citizen cosponsors

0

In Congress

3/ 435

House Reps cosponsoring

Introduced 2025-02-06

Joining the bill

Legislative timeline

  1. 2025-02-06 · house · IntroReferral

    Referred to the House Committee on Energy and Commerce.

  2. 2025-02-06 · IntroReferral

    Introduced in House

  3. 2025-02-06 · IntroReferral

    Sponsor introductory remarks on measure. (CR H519)

  4. 2025-02-06 · IntroReferral

    Introduced in House

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.